Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials

Kiladjian, JJ; Vannucchi, AM; Gerds, AT; Gupta, V; Verstovsek, S; Egyed, M; Platzbecker, U; Mayer, J; Grosicki, S; Illés, A; Wozny, T; Oh, ST; McLornan, D; Kirgner, I; Yoon, SS; Harrison, CN; Klencke, B; Huang, M; Kawashima, J; Mesa, R

Kiladjian, JJ (通讯作者)，Univ Paris, Hop St Louis, AP HP, Ctr Invest Clin,INSERM, Paris, France.

HEMASPHERE, 2023; 7 (11):

Abstract

The oral activin A receptor type I, Janus kinase 1 (JAK1), and JAK2 inhibitor momelotinib demonstrated symptom, spleen, and anemia benefits in interme......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索